The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors

OBJECTIVES: To present our experience of treating steroid-dependent nephrotic syndrome (SDNS) in children with repeated doses of rituximab (RTX) with a relatively long follow-up, and to discuss the role of the histopathology type and previous immune-suppressor (IS) drugs on the outcome of these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Salloum, Abdullah A., Al Herbish, Adi J., Al Hissi, Mohammed A., Abdalla, Mohammed S., Salim, Suha B., Farhat, Afrah H., Shagal, Reem A., Othman, Abduldafaee, Alshaiban, Abdulelah, Temsah, Mohamad-Hani A., Al-Eyadhy, Ayman A., Alhasan, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749693/
https://www.ncbi.nlm.nih.gov/pubmed/35830996
http://dx.doi.org/10.15537/smj.2022.43.7.20210727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749693/
https://www.ncbi.nlm.nih.gov/pubmed/35830996
http://dx.doi.org/10.15537/smj.2022.43.7.20210727

Ejemplares similares